Table 2 The detailed differences between survival group and mortality group in heterotaxy syndrome
Survival group (%) | Mortality group (%) | |
|---|---|---|
N | 23 | 16 |
Observation period (mo) | 131.1 ± 88.5 | 32.9 ± 68.9 |
Male | 16 (69.6) | 9 (56.3) |
Isomerism | ||
Right | 18 (78.3) | 15 (93.8) |
Left | 4 (17.4) | 0 (0) |
Ambiguous | 1 (4.3) | 1 (6.3) |
Age of 1st palliation (mo) | 4.1 ± 3.1 | 1.5 ± 2.3 |
1st palliation | ||
BT shunt | 12 (52.2) | 13 (81.2) |
PAB | 1 (4.3) | 1 (6.3) |
BCPS | 10 (43.4) | 2 (12.5) |
Birth weight (kg) | ||
< 3p | 2 (8.7) | 5 (31.3) |
3-25p | 10 (43.4 | 6 (37.5) |
25-50p | 5 (21.7) | 3 (18.8) |
>50p | 6 (26.1) | 2 (12.5) |
Body weight at discharge (kg) | ||
< 3p | 4 (17.4) | 12 (75.0) |
3-25p | 10 (43.4) | 3 (18.8) |
25-50p | 3 (13.0) | 0 (0) |
>50p | 6 (26.1) | 1 (6.3) |
AVVR > mild | 9 (39.1) | 11 (68.8) |
Pulmonary atresia | 9 (39.1) | 7 (43.8) |
Pulmonary vein stenosis at diagnosis | 4 (17.4) | 6 (37.5) |
Duration of hospitalization (days) | 29.8 ± 17.3 | 59.1 ± 88.0 |
Duration of ICU care (days) | 9.0 ± 5.9 | 32.5 ± 48.6 |
Duration of mechanical ventilation (days) | 3.0 ± 2.3 | 26.4 ± 47.0 |
Duration of IV inotropics (days) | 6.4 ± 6.4 | 17.8 ± 25.5 |
Duration of TPN (days) | 12.1 ± 11.5 | 24.0 ± 30.7 |
Antiarrhythmic at discharge | 3 (13.0%) | 2 (12.5%) |
O2 saturation at discharge (%) | 88.1 ± 6.4 | 78.9 ± 3.3 |